Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML-Reference-Cited by-同舟云学术

Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML

Published:2013-03-18 Issue:9 Volume:27 Page:1926-1928
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Takagi M,Piao J,Lin L,Kawaguchi H,Imai C,Ogawa A,Watanabe A,Akiyama K,Kobayashi C,Mori M,Ko K,Sugimoto M,Mizutani S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201382.pdf

Reference12 articles.

1. Loh ML . Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J haematol 2011; 152: 677–687.

2. Kitahara M, Koike K, Kurokawa Y, Sawai N, Mori T, Nakazawa K et al. Lupus nephritis in juvenile myelomonocytic leukemia. Clin Nephrol 1999; 51: 314–318.

3. Niemela JE, Lu L, Fleisher TA, Davis J, Caminha I, Natter M et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood 2011; 117: 2883–2886.

4. Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood 2011; 117: 2887–2890.

5. Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood 2007; 109: 5477–5480.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoallelic KRAS (G13C) mutation triggers dysregulated expansion in induced pluripotent stem cell-derived hematopoietic progenitor cells;Stem Cell Research & Therapy;2024-04-16

2. Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features;Journal of Clinical Immunology;2023-08-29

3. Distinct αβ double-negative T cells discriminate between autoimmune lymphoproliferative syndrome and RAS-associated lymphoproliferative disease;2023-06-05

4. Germline Neurofibromin 1 mutation enhances the anti‐tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity;British Journal of Haematology;2023-05-05

5. Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment;Blood Advances;2021-11-23